Megace (Megestrol Acetate) - Summary

MEGACE SUMMARY

Megace^®
(megestrol acetate, USP)
Oral Suspension

MEGACE^® (megestrol acetate, USP) Oral Suspension contains megestrol acetate, a synthetic derivative of the naturally occurring steroid hormone, progesterone.

MEGACE Oral Suspension is indicated for the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS).

MEGACE NEWS HIGHLIGHTS

Published Studies Related to Megace (Megestrol)

Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. [2008.04.01]

Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C). [2008]

Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. [2007.02]

Effects of muscle strength training and megestrol acetate on strength, muscle mass, and function in frail older people. [2007.01]

Megestrol attenuates the hormonal response to CCK-4-induced panic attacks. [2006]

more>>

Clinical Trials Related to Megace (Megestrol)

Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension [Terminated]

Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-Related Weight Loss [Completed]

Evaluating the Effect of Food on Absorption of Megace ES [Completed]

Treatment of Cancer-Associated Anorexia Using Megestrol Acetate Concentrated Suspension [Terminated]

Treatment of Cancer-Anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients [Terminated]

more>>